211 related articles for article (PubMed ID: 10532235)
1. NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.
Naganagowda GA; Gururaja TL; Satyanarayana J; Levine MJ
J Pept Res; 1999 Oct; 54(4):290-310. PubMed ID: 10532235
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of O-glycosylated C-terminal leucine zipper domain of human salivary mucin (MUC7).
Narasimhamurthy S; Naganagowda GA; Janagani S; Gururaja TL; Levine MJ
J Biomol Struct Dyn; 2000 Aug; 18(1):145-54. PubMed ID: 11021659
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and conformational features of human salivary mucin C-terminal derived peptide epitope carrying Thomsen-Friedenreich antigen: implications for its role in self-association.
Satyanarayana J; Gururaja TL; Narasimhamurthy S; Naganagowda GA; Levine MJ
Biopolymers; 2001 Apr; 58(5):500-10. PubMed ID: 11241221
[TBL] [Abstract][Full Text] [Related]
4. Structure and dynamics of mucin-like glycopeptides. Examination of peptide chain expansion and peptide-carbohydrate interactions by stochastic dynamics simulations.
Butenhof KJ; Gerken TA
Biochemistry; 1993 Mar; 32(10):2650-63. PubMed ID: 8448122
[TBL] [Abstract][Full Text] [Related]
5. N.m.r. study of interaction between sugar and peptide moieties in mucin-type model glycopeptides.
Mimura Y; Yamamoto Y; Inoue Y; Chûjô R
Int J Biol Macromol; 1992 Oct; 14(5):242-8. PubMed ID: 1419961
[TBL] [Abstract][Full Text] [Related]
6. Structural features of the human salivary mucin, MUC7.
Gururaja TL; Ramasubbu N; Venugopalan P; Reddy MS; Ramalingam K; Levine MJ
Glycoconj J; 1998 May; 15(5):457-67. PubMed ID: 9881747
[TBL] [Abstract][Full Text] [Related]
7. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity and poly-L-proline II conformation of the tandem repeat sequence of human salivary mucin glycoprotein (MG2).
Antonyraj KJ; Karunakaran T; Raj PA
Arch Biochem Biophys; 1998 Aug; 356(2):197-206. PubMed ID: 9705210
[TBL] [Abstract][Full Text] [Related]
9. Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1.
Gururaja TL; Levine JH; Tran DT; Naganagowda GA; Ramalingam K; Ramasubbu N; Levine MJ
Biochim Biophys Acta; 1999 Apr; 1431(1):107-19. PubMed ID: 10209284
[TBL] [Abstract][Full Text] [Related]
10. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
11. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
12. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
[TBL] [Abstract][Full Text] [Related]
13. Determination of the site-specific O-glycosylation pattern of the porcine submaxillary mucin tandem repeat glycopeptide. Model proposed for the polypeptide:galnac transferase peptide binding site.
Gerken TA; Owens CL; Pasumarthy M
J Biol Chem; 1997 Apr; 272(15):9709-19. PubMed ID: 9092502
[TBL] [Abstract][Full Text] [Related]
14. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
[TBL] [Abstract][Full Text] [Related]
15. Glycosylations versus conformational preferences of cancer associated mucin core.
Schuman J; Qiu D; Koganty RR; Longenecker BM; Campbell AP
Glycoconj J; 2000 Dec; 17(12):835-48. PubMed ID: 11511808
[TBL] [Abstract][Full Text] [Related]
16. A concise methodology for the stereoselective synthesis of O-glycosylated amino acid building blocks: complete 1H NMR assignments and their application in solid-phase glycopeptide synthesis.
Satyanarayana J; Gururaja TL; Naganagowda GA; Ramasubbu N; Levine MJ
J Pept Res; 1998 Sep; 52(3):165-79. PubMed ID: 9774229
[TBL] [Abstract][Full Text] [Related]
17. Structurally defined synthetic cancer vaccines: analysis of structure, glycosylation and recognition of cancer associated mucin, MUC-1 derived peptides.
Liu X; Sejbal J; Kotovych G; Koganty RR; Reddish MA; Jackson L; Gandhi SS; Mendonca AJ; Longenecker BM
Glycoconj J; 1995 Oct; 12(5):607-17. PubMed ID: 8595249
[TBL] [Abstract][Full Text] [Related]
18. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
Gerken TA; Gilmore M; Zhang J
J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of peptide substrates for mucin-type O-glycosylation.
Kirnarsky L; Nomoto M; Ikematsu Y; Hassan H; Bennett EP; Cerny RL; Clausen H; Hollingsworth MA; Sherman S
Biochemistry; 1998 Sep; 37(37):12811-7. PubMed ID: 9737858
[TBL] [Abstract][Full Text] [Related]
20. Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono-, di-, tri-, and hexasaccharide glycodomains.
Coltart DM; Royyuru AK; Williams LJ; Glunz PW; Sames D; Kuduk SD; Schwarz JB; Chen XT; Danishefsky SJ; Live DH
J Am Chem Soc; 2002 Aug; 124(33):9833-44. PubMed ID: 12175243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
